» Articles » PMID: 38786191

Risk Factors for Therapeutic Failure and One-Year Mortality in Patients with Intramedullary Nail-Associated Infection After Trochanteric and Subtrochanteric Hip Fracture Repair

Overview
Specialty Pharmacology
Date 2024 May 24
PMID 38786191
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the implications of trochanteric and subtrochanteric intramedullary (IM) nail infection for patients with hip fracture, little is known about risk factors for therapeutic failure and mortality in this population. We performed a retrospective observational analysis including patients diagnosed with trochanteric and subtrochanteric IM nail infection at a Spanish academic hospital during a 10-year period, with a minimum follow-up of 22 months. Of 4044 trochanteric and subtrochanteric IM nail implants, we identified 35 cases of infection during the study period (0.87%), 17 of which were chronic infections. Patients with therapeutic failure (n = 10) presented a higher average Charlson Comorbidity Index (CCI) (5.40 vs. 4.21, 0.015, CI 0.26-2.13) and higher rates of polymicrobial (OR 5.70, 0.033, CI 1.14-28.33) and multidrug-resistant (OR 7.00, 0.027, CI 1.24-39.57) infections. Upon multivariate analysis, polymicrobial infection and the presence of multidrug-resistant pathogens were identified as independent risk factors for therapeutic failure. Implant retention was associated with an increased risk of failure in chronic infection and was found to be an independent risk factor for overall one-year mortality in the multivariate analysis. Our study highlights the importance of broad-spectrum empirical antibiotics as initial treatment of trochanteric and subtrochanteric IM nail-associated infection while awaiting microbiological results. It also provides initial evidence for the importance of implant removal in chronic IM-nail infection.

Citing Articles

Correlation between Charlson comorbidity index and surgical prognosis in elderly patients with femoral neck fractures: a retrospective study.

Wang P, Guo S BMC Musculoskelet Disord. 2024; 25(1):678.

PMID: 39210355 PMC: 11360289. DOI: 10.1186/s12891-024-07814-2.

References
1.
Sukhonthamarn K, Tan T, Xu C, Kuo F, Lee M, Citak M . Determining Diagnostic Thresholds for Acute Postoperative Periprosthetic Joint Infection. J Bone Joint Surg Am. 2020; 102(23):2043-2048. DOI: 10.2106/JBJS.20.00257. View

2.
Klima M . Mechanical Complications After Intramedullary Fixation of Extracapsular Hip Fractures. J Am Acad Orthop Surg. 2022; 30(24):e1550-e1562. DOI: 10.5435/JAAOS-D-22-00213. View

3.
Velez M, Palacios-Barahona U, Paredes-Laverde M, Ramos-Castaneda J . Factors associated with mortality due to trochanteric fracture. A cross-sectional study. Orthop Traumatol Surg Res. 2020; 106(1):135-139. DOI: 10.1016/j.otsr.2019.06.022. View

4.
Zmistowski B, Fedorka C, Sheehan E, Deirmengian G, Austin M, Parvizi J . Prosthetic joint infection caused by gram-negative organisms. J Arthroplasty. 2011; 26(6 Suppl):104-8. DOI: 10.1016/j.arth.2011.03.044. View

5.
Yoon J, Park S, Kim T, Im G . Cut-out risk factor analysis after intramedullary nailing for the treatment of extracapsular fractures of the proximal femur: a retrospective study. BMC Musculoskelet Disord. 2022; 23(1):107. PMC: 8809036. DOI: 10.1186/s12891-022-05054-w. View